Regulation of bone resorption and osteoclast survival by nitric oxide: Possible involvement of NMDA‐receptor
- 6 March 2003
- journal article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 88 (6) , 1145-1156
- https://doi.org/10.1002/jcb.10463
Abstract
Nitric oxide has been shown to play an important role in regulation of bone resorption. However, the role of endogenous nitric oxide on osteoclast activity remains still controversial. In this work, using RT‐PCR amplification, we demonstrated that rabbit mature osteoclasts express mRNA encoding for neuronal nitric oxide synthase suggesting that this enzyme could be involved in basal nitric oxide production in these cells. Then we assessed the effect of carboxy‐PTIO, a nitric oxide scavenger, on in vitro bone resorption and osteoclast survival. Carboxy‐PTIO (10–100 μM) inhibited osteoclastic bone resorption in a dose dependent manner and induced osteoclast apoptosis by a mechanism involving caspase 3 activation. These results suggest that basal concentration of endogenous nitric oxide may be essential for normal bone resorption by supporting osteoclast survival. Because osteoclasts express N‐methyl‐d‐aspartate‐receptor (NMDA‐R), we hypothesized that in osteoclasts NMDA‐R may be involved in nitric oxide production as in neuronal cells. We confirmed that blockade of NMDA‐R with specific non‐competitive antagonists, MK801 and DEP, strongly inhibited bone resorption. As for carboxy‐PTIO, we showed that blockade of NMDA‐R by both antagonists induced osteoclast apoptosis in a dose dependent manner by a mechanism dependent on caspase 3 activation. Intracellular calcium concentration in osteoclasts decreased within minutes in the presence of both antagonists. Finally, MK801‐induced osteoclast apoptosis was partially reversed in the presence of small amount of SNAP (100 nM), a nitric oxide donor, suggesting that the effect of NMDA‐R on osteoclast apoptotic cell death could be due to a decrease in nitric oxide production. Taken together, our results are consistent with the hypothesis that NMDA‐R on osteoclasts could have a similar function as those in neuronal cells, i.e., to allow a calcium influx, which in turn activates a constitutive neuronal nitric oxide synthase. Nitric oxide generated by this pathway may be essential for osteoclast survival and hence for normal bone resorption. J. Cell. Biochem. 88: 1145–1156, 2003.Keywords
This publication has 39 references indexed in Scilit:
- Defective Bone Formation and Anabolic Response to Exogenous Estrogen in Mice with Targeted Disruption of Endothelial Nitric Oxide Synthase**This study was supported by grants from the Arthritis Research Campaign (UK) and the Medical Research Council (UK).Endocrinology, 2001
- Endothelial Nitric Oxide Synthase Gene-Deficient Mice Demonstrate Marked Retardation in Postnatal Bone Formation, Reduced Bone Volume, and Defects in Osteoblast Maturation and ActivityThe American Journal of Pathology, 2001
- Active NMDA glutamate receptors are expressed by mammalian osteoclastsThe Journal of Physiology, 1999
- Nitric Oxide Synthase Expression in Bone CellsBone, 1998
- NMDA-R1 subunit of the cerebral cortex co-localizes with neuronal nitric oxide synthase at pre- and postsynaptic sites and in spinesBrain Research, 1997
- Interaction of Nitric Oxide Synthase with the Postsynaptic Density Protein PSD-95 and α1-Syntrophin Mediated by PDZ DomainsPublished by Elsevier ,1996
- Nitric oxide and boneJournal of Bone and Mineral Research, 1996
- Quantification of the collagenolytic activity of isolated osteoclasts by enzyme-linked immunosorbent assayJournal of Bone and Mineral Research, 1996
- Improved detection of nitric oxide radical (NO•) production in an activated macrophage culture with a radical scavenger, car☐y PTIO, and Griess reagentFEBS Letters, 1995
- Bidirectional regulation of osteoclast function by nitric oxide synthase isoforms.Proceedings of the National Academy of Sciences, 1995